Talk Presenting Companies (Theatre A) track
Technologies and Tools: CellNBetter Inc.
Wed, Nov 11, 2026 · 10:10–10:20 AM CET Koelnmesse
About this session
CellNBetter, Inc., a 2025 KBSI research-institute spin-off in Daejeon, Korea, develops LOCAT™, a one-stop multi-organ automated cell-culture and drug-evaluation platform. Built on 20+ years of biochip and 3D tissue-engineering research, it replaces labor-intensive preclinical testing with validated automation, ready-to-use kits, and data analysis-supporting the shift to NAMs. We seek partners for co-development, CRO integration, European distribution, and NAM regulatory collaboration.
Speaker
-
Executive Director - Business Development · CellNBetter Inc.
Speaker